Foresite Capital Management Iii, LLC Pacific Biosciences Of California, Inc. Transaction History

Foresite Capital Management Iii, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$3.99 - $7.82 $4.53 Million - $8.88 Million	-1,135,000 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$3.52 - $5.55 $4 Million - $6.3 Million	1,135,000 New	1,135,000 $6.14 Million
Q1 2018 May 15, 2018	SELL	$2.05 - $3.23 $917,415 - $1.45 Million	-447,520 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$2.59 - $5.44 $1.82 Million - $3.82 Million	-702,480 Reduced 61.09%	447,520 $1.18 Million
Q3 2017 Nov 13, 2017	SELL	$3.2 - $5.57 $320,000 - $557,000	-100,000 Reduced 8.0%	1,150,000 $6.04 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,250,000	1,250,000 $4.45 Million

260

230M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $351M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Foresite Capital Management Iii, LLC, based on Form 13F filings with the SEC.

Stay updated on Foresite Capital Management Iii, LLC with notifications on news.